Franklin Biolabs, a new genetic medicines contract research organization (CRO), will be the services and production arm, providing comprehensive solutions from discovery to development and distribution for the global genetic medicines industry.
Alongside GEMMABio, Franklin Biolabs will advance cell & gene therapy research and deliver therapeutics to patients around the world significantly faster.